JOHNSON & JOHNSON Share-Based Compensation 2007-2026 | JNJ
Beta
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is JOHNSON & JOHNSON's current share-based compensation?
JOHNSON & JOHNSON (JNJ) annual share-based compensation for 2025 was $1.35B, a 15.14% increase from 2024. JOHNSON & JOHNSON share-based compensation for the quarter ending March 29, 2026 was $300.0M.
What was JOHNSON & JOHNSON's share-based compensation in 2024?
JOHNSON & JOHNSON annual share-based compensation for 2024 was $1.18B, a 1.20% increase from 2023.
What was JOHNSON & JOHNSON's share-based compensation in 2023?
JOHNSON & JOHNSON annual share-based compensation for 2023 was $1.16B, a 2.38% increase from 2022.
What is JOHNSON & JOHNSON's 4-year share-based compensation CAGR?
JOHNSON & JOHNSON share-based compensation grew at a compound annual growth rate (CAGR) of 7.74% from FY2021 to FY2025, going from $1.00B to $1.35B over 4 years.
Share-Based Compensation History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.7%
FY2019
$977.0M
→
FY2025
$1.35B
07081011121314161718192122232425
5 years selected
Share-Based Compensation History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.35B | +15.1% | 10-K |
| FY2024 | $1.18B | +1.2% | 10-K |
| FY2023 | $1.16B | +2.4% | 10-K |
| FY2022 | $1.14B | +12.9% | 10-K |
| FY2021 | $1.00B | +2.9% | 10-K |
| FY2019 | $977.0M | -0.1% | 10-K |
| FY2018 | $978.0M | +1.7% | 10-K |
| FY2017 | $962.0M | +10.1% | 10-K |
| FY2016 | $874.0M | +10.4% | 10-K |
| FY2014 | $792.0M | +8.8% | 10-K |
| FY2013 | $728.0M | +10.0% | 10-K |
| FY2012 | $662.0M | +7.8% | 10-K |
| FY2011 | $614.0M | -2.2% | 10-K |
| FY2010 | $628.0M | +0.2% | 10-K |
| FY2008 | $627.0M | -10.2% | 10-K |
| FY2007 | $698.0M | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →